PANK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.452600E-01
Normal-vs-Stage2
5.914800E-01
Normal-vs-Stage3
8.325400E-01
Normal-vs-Stage4
1.215440E-01
Stage1-vs-Stage2
9.486400E-01
Stage1-vs-Stage3
3.039400E-01
Stage1-vs-Stage4
7.698500E-02
Stage2-vs-Stage3
4.210600E-01
Stage2-vs-Stage4
8.135700E-03
Stage3-vs-Stage4
6.592100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.603400E-01
Normal-vs-AfricanAmerican
3.150000E-01
Normal-vs-Asian
5.631800E-01
Caucasian-vs-AfricanAmerican
2.539200E-01
Caucasian-vs-Asian
5.497400E-01
AfricanAmerican-vs-Asian
7.914200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.466000E-01
Normal-vs-Female
5.805000E-01
Male-vs-Female
5.597400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.253400E-01
Normal-vs-Age(41-60Yrs)
4.616800E-01
Normal-vs-Age(61-80Yrs)
6.578000E-01
Normal-vs-Age(81-100Yrs)
8.472800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.887400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.532400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.884800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.508430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.509700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.071600E-01
Normal-vs-Daily Drinker
9.664600E-01
Normal-vs-Weekly Drinker
6.685600E-01
Normal-vs-Occasional Drinker
5.301000E-01
Normal-vs-Social Drinker
6.571400E-01
Non Drinker-vs-Daily Drinker
3.513200E-01
Non Drinker-vs-Weekly Drinker
8.045600E-01
Non Drinker-vs-Occasional Drinker
5.294000E-01
Non Drinker-vs-Social Drinker
9.615000E-01
Daily Drinker-vs-Weekly Drinker
3.228400E-01
Daily Drinker-vs-Occasional Drinker
1.501950E-01
Daily Drinker-vs-Social Drinker
3.863600E-01
Weekly Drinker-vs-Occasional Drinker
7.847400E-01
Weekly Drinker-vs-Social Drinker
7.866400E-01
Occasional Drinker-vs-Social Drinker
5.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.513850E-01
Normal-vs-Grade 2
7.587900E-02
Normal-vs-Grade 3
4.976400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.747800E-02
Grade 1-vs-Grade 3
6.090400E-02
Grade 1-vs-Grade 4
1.513850E-01
Grade 2-vs-Grade 3
4.382400E-01
Grade 2-vs-Grade 4
7.587900E-02
Grade 3-vs-Grade 4
4.976400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.132600E-01
Normal-vs-NonDiabetic
6.281400E-01
Diabetic-vs-NonDiabetic
5.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.096600E-01
Normal-vs-NoPancreatitis
6.470400E-01
Pancreatitis-vs-NoPancreatitis
9.555400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.307400E-01
Normal-vs-N1
5.774400E-01
N0-vs-N1
7.029800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.471800E-01
Normal-vs-TP53-NonMutant
5.563400E-01
TP53-Mutant-vs-TP53-NonMutant
2.602800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
